+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tuberculosis Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular, Nonmolecular), Test Type, End User, Application - Global Forecast 2025-2030- Product Image
Tuberculosis Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular, Nonmolecular), Test Type, End User, Application - Global Forecast 2025-2030- Product Image
Sale

Tuberculosis Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular, Nonmolecular), Test Type, End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4985929
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rapidly evolving tuberculosis diagnostics market is undergoing transformative change, as demand surges for effective technologies that drive earlier detection and equitable access. Senior decision-makers across the healthcare landscape are navigating shifting regulatory, economic, and supply chain conditions in pursuit of diagnostic excellence and sustainable market leadership.

Market Snapshot: Tuberculosis Diagnostics Market Overview

The tuberculosis diagnostics market grew from USD 3.17 billion in 2024 to USD 3.35 billion in 2025. It is expected to continue growing at a CAGR of 5.51%, reaching USD 4.38 billion by 2030. Market expansion is being propelled by advancements in molecular diagnostic technologies, increased investment in digital health integration, and ongoing efforts to close diagnostic gaps globally.

Scope & Segmentation

This comprehensive research defines in detail the breadth of the tuberculosis diagnostics market and its segmentation. The study addresses core offerings, application areas, and regional variances to deliver targeted operational and strategic insights for decision-makers:

  • Product Types: Instruments, kits, and reagents essential for diverse testing workflows supporting both centralized labs and point-of-care facilities.
  • Technology Modalities: Molecular techniques, including genotypic assays and nucleic acid amplification, as well as nonmolecular approaches like imaging and immunological assays.
  • Test Types: Detection tests, such as blood, culture-based, molecular, skin, and smear microscopy; plus drug susceptibility tests using both molecular and phenotypic DST methods.
  • End Users: Clinics, hospitals, and reference laboratories representing the spectrum from rural health outposts to advanced analytical centers.
  • Application Areas: Screening for active (pulmonary and extrapulmonary) and latent tuberculosis, critical in both prevention and disease management.
  • Geographical Coverage: Americas (with detailed US regional analysis), Europe, Middle East, Africa, and Asia-Pacific, reflecting diverse healthcare infrastructure, funding models, and regulatory frameworks.
  • Key Companies Monitored: Industry leaders including Cepheid, Becton, Dickinson and Company, Hain Lifescience GmbH, Molbio Diagnostics, bioMérieux, Abbott Molecular, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, and Hologic.

Key Takeaways for Senior Decision-Makers

  • Integration of molecular and digital technologies is transforming traditional tuberculosis diagnostic paradigms, fostering earlier intervention and agile outbreak response.
  • Multi-faceted segmentation highlights a demand shift toward flexible diagnostic platforms able to operate in varied care settings, from highly resourced hospitals to remote clinics.
  • Collaboration between public and private sectors is essential to scale up innovative solutions and to promote widespread adoption of point-of-care diagnostics in underserved regions.
  • Strategic alliances and partnerships remain critical for broadening test portfolios, navigating regulatory complexity, and optimizing regional accessibility.
  • Operational resilience depends on local manufacturing partnerships and diversified procurement strategies to mitigate risks related to supply disruptions and policy shifts.

Tariff Impact: Adapting to Regulatory and Economic Change

Recent adjustments in United States trade tariffs are introducing new challenges to the tuberculosis diagnostics supply chain. Tariff-related increases in capital expenditure for diagnostic instruments and consumables are compelling laboratories to reconsider procurement. There is a notable trend toward strengthening domestic manufacturing and exploring sourcing alternatives in regions with favorable trade arrangements. These moves foster long-term resilience but may impact short-term test accessibility and operational costs.

Methodology & Data Sources

This report deploys a mixed-methods approach to ensure accuracy and actionable insight. Secondary research encompassed peer-reviewed publications, regulatory filings, industry white papers, and patent data reviews. These findings were validated by direct engagement with clinicians, laboratory directors, procurement specialists, and policy experts, creating a nuanced picture of current challenges and emerging opportunities. Quantitative and qualitative insights were synthesized through robust triangulation methods.

Why This Report Matters

  • Provides strategic clarity for investment in tuberculosis diagnostics by illuminating trends across product innovation, supply chain resilience, and regional adoption patterns.
  • Supports informed decision-making with actionable segmentation analysis, revealing where and how opportunities are emerging within shifting global healthcare landscapes.
  • Enables ongoing risk mitigation strategies by outlining current and anticipated impacts of trade policies, technology innovation, and cross-sector collaboration.

Conclusion

With dynamic technologies and complex market forces at play, the tuberculosis diagnostics sector demands agile and evidence-based leadership. This report equips senior decision-makers with the depth and clarity needed to guide resilient, impactful strategies in a rapidly evolving market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of CRISPR-based point-of-care assays for rapid tuberculosis detection
5.2. Expansion of AI-enhanced imaging technologies for automated sputum smear analysis in TB screening
5.3. Scaling up portable molecular diagnostic platforms to enable community-based TB screening in remote areas
5.4. Adoption of multiplexed nucleic acid amplification tests for drug resistant TB detection worldwide
5.5. Emergence of next generation sequencing for comprehensive resistance profiling and epidemiological tracing
5.6. Development of breath based volatile organic compound sensors for non invasive TB screening at point of care
5.7. Integration of digital health platforms with diagnostics for real time TB case monitoring and management
5.8. Government subsidy programs driving adoption of rapid molecular TB tests in high burden regions
5.9. Strategic partnerships between diagnostic manufacturers and NGOs to accelerate low cost TB test distribution
5.10. Trend of regulatory approvals for novel point of care TB molecular diagnostics in emerging markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tuberculosis Diagnostics Market, by Product
8.1. Introduction
8.2. Consumables
8.2.1. Kits
8.2.2. Reagents
8.3. Instruments
9. Tuberculosis Diagnostics Market, by Technology
9.1. Introduction
9.2. Molecular
9.2.1. Genotypic Assays
9.2.2. Nucleic Acid Amplification Tests
9.3. Nonmolecular
9.3.1. Imaging
9.3.2. Immunological Assays
10. Tuberculosis Diagnostics Market, by Test Type
10.1. Introduction
10.2. Detection Test
10.2.1. Blood Tests
10.2.2. Culture-Based Tests
10.2.3. Molecular Tests
10.2.4. Skin Tests
10.2.5. Smear Microscopy
10.3. Drug Susceptibility Testing
10.3.1. Molecular Dst
10.3.2. Phenotypic Dst
11. Tuberculosis Diagnostics Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Reference Laboratories
12. Tuberculosis Diagnostics Market, by Application
12.1. Introduction
12.2. Active Tb
12.2.1. Extrapulmonary Tb
12.2.2. Pulmonary Tb
12.3. Latent Tb
13. Americas Tuberculosis Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Tuberculosis Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Tuberculosis Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Cepheid, Inc.
16.3.2. Becton, Dickinson and Company
16.3.3. Hain Lifescience GmbH
16.3.4. Molbio Diagnostics Private Limited
16.3.5. bioMérieux SA
16.3.6. Abbott Molecular Inc.
16.3.7. Thermo Fisher Scientific Inc.
16.3.8. Roche Diagnostics International AG
16.3.9. QIAGEN N.V.
16.3.10. Hologic, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TUBERCULOSIS DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TUBERCULOSIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TUBERCULOSIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. TUBERCULOSIS DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TUBERCULOSIS DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GENOTYPIC ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY GENOTYPIC ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CULTURE-BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CULTURE-BASED TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY SKIN TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY SKIN TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY SMEAR MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY SMEAR MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR DST, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR DST, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PHENOTYPIC DST, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PHENOTYPIC DST, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY EXTRAPULMONARY TB, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY EXTRAPULMONARY TB, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PULMONARY TB, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PULMONARY TB, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LATENT TB, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY LATENT TB, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 132. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 133. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 134. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 135. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 138. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 139. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 140. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 141. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 144. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 145. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 146. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 147. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 152. CANADA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 153. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 154. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 155. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 156. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 161. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 162. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 163. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 166. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 167. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 168. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 169. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 174. MEXICO TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 265. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 268. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 269. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 272. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 273. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 274. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 275. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 278. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 279. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 280. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 281. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 286. GERMANY TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 287. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 288. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 289. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 290. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 291. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 294. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 295. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 296. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 297. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 300. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 301. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 302. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 303. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2018-2024 (USD MILLION)
TABLE 308. FRANCE TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY ACTIVE TB, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY NONMOLECULAR, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DETECTION TEST, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA TUBERCULOSIS DIAGNOSTICS MA

Samples

Loading
LOADING...

Companies Mentioned

  • Cepheid, Inc.
  • Becton, Dickinson and Company
  • Hain Lifescience GmbH
  • Molbio Diagnostics Private Limited
  • bioMérieux SA
  • Abbott Molecular Inc.
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics International AG
  • QIAGEN N.V.
  • Hologic, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.38 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Tuberculosis Testing Market by Test Type (Culture Test, Immunological Test, Molecular Test), End User (Clinics, Hospitals, Reference Laboratory), Technology, Sample Type, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Tuberculosis Testing Market by Test Type (Culture Test, Immunological Test, Molecular Test), End User (Clinics, Hospitals, Reference Laboratory), Technology, Sample Type, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Tuberculosis Diagnostics: Market Share, and Growth Analysis by Product Type (Tests, Devices, Software), Application, End User, Technology - Product Image

Tuberculosis Diagnostics: Market Share, and Growth Analysis by Product Type (Tests, Devices, Software), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Tuberculosis Diagnostics - Global Strategic Business Report - Product Image

Tuberculosis Diagnostics - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Tuberculosis Diagnostics Market Opportunities and Strategies to 2033 - Product Image

Tuberculosis Diagnostics Market Opportunities and Strategies to 2033

  • Report
  • 353 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.